HFSA 2022 | Pfizer Medical Information

Congress Materials

Medical Information

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

I am a U.S. Healthcare ProfessionalYes, I am a U.S. Healthcare Professional

I am a U.S. Patient / CaregiverNo, go back to the patient portal

Select I am a U.S. Patient / CaregiverNo, go back to the patient portal

The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Congress materials may include information for which the product is not approved and/or inconsistent with the product uses described in the Prescribing Information. Pfizer does not suggest or recommend the use of Pfizer Products in any manner other than as described in the Prescribing Information.

Back to Congresses

Poster

Ahmad Masri, Yong Chen, A. Carmine Colavecchia, Jose Maria Jimenez Alvir, Darrin Benjumea, Aaron Crowley, Priti Jhingran, Matthew Kent, Jen Wogen, Rahul Bhambri September 30, 2022 HFSA 2022 Transthyretin Amyloidosis (ATTR)

Clinical Characteristics of Patients With Concurrent Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis

View Presentation